1-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)ethanone, 98%, 1g

tert-butyl 2-(aminomethyl)-1-oxa-8-azaspiro[4.5]decane-8-carboxylate hydrochloride, 100mg

6-Chloro-4-formylpyridine-3-carboxylic acid, 95+%, 1g

(3-Methyl-2-oxo-2,3-dihydro-benzoimidazol-1-yl)-acetic acid, 95.0%, 1g

Phthalazine>98.0%(GC)(T)25g

1-(4-Methoxy-benzenesulfonyl)-piperidine-2-carboxylic acid, 95.0%, 250mg

Methyl 2,5-Dihydroxycinnamate>96.0%(HPLC)10mg

5-(Thiophen-2-yl)-1,2-oxazole-3-carboxamide, 95%, 100mg

(Z)-1-benzyl-3,3-difluoro-4-(4-fluorobenzylidene)piperidine, 98%, 5g

1,3-Diethylurea, 95.0%, 5g

1,1,2-Trimethoxyethane>98.0%(GC)100mL

Recipiente di reazione a flangia piatta, cilindrico, graduato, con camicia di rinvenimento e sottovuoto e valvola di scarico, DN 150, 500 ml, 120 mm, 1 Pezzo

4-(chloromethyl)-2-(2-methylphenyl)-1,3-thiazole, 95.0%, 5g